Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial (Q34738944)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

human papillomavirus 16

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

human papilloma virus

1 reference

object named as

human papillomavirus

29 September 2024

based on heuristic

inferred from title

object named as

Gina Ogilvie

12

0 references

Shelly A McNeil

object named as

Shelly McNeil

6

0 references

1

object named as

Mel Krajden

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

7

object named as

Deborah Money

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

13

object named as

Martin Petric

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

object named as

Ron Chow

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

Darrel Cook

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Amanda Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Wendy Mei

5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Marc Dionne

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Karuna P Karunakaran

9

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Joel M Palefsky

10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Simon Dobson

11

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Clinical and Vaccine Immunology

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

418-423

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Multiplexed serologic assay for nine anogenital human papillomavirus types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Generation of HPV pseudovirions using transfection and their use in neutralization assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

7 July 2018

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

26 October 2018

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

26 October 2018

Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3067374

26 October 2018

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

1 reference

https://pubmed.ncbi.nlm.nih.gov/21248158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in healthy Chinese women from Hong Kong

1 reference

https://pubmed.ncbi.nlm.nih.gov/21248158

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/CVI.00489-10

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34738944&oldid=2254308387"